Desvenlafaxine succinate (DVS) efficacy for the relief of vasomotor symptoms (VMS) associated with menopause: A double-blind, placebo-controlled trial. Meeting Abstract

publication date

  • September 1, 2007

webpage

published in

start page

  • S243

end page

  • S243

volume

  • 88